Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Timber Pharmaceuticals Inc
(NY:
TMBR
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EST, Nov 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Timber Pharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
Timber Pharmaceuticals Receives Court Approval of All First Day Motions to Support Business Operations & Discloses Communication From NYSE American
November 28, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
September 18, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR
August 29, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
Crude Oil Falls; Nikola Shares Plummet
August 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 21, 2023
Via
Benzinga
Why Timber Pharmaceuticals Stock Is Skyrocketing Today
August 21, 2023
Timber Pharmaceuticals, Inc. (NYSE: TMBR) has
Via
Benzinga
Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher
August 21, 2023
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders
August 21, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Is Skillz (SKLZ) Stock Up 20% Today?
August 21, 2023
Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program.
Via
InvestorPlace
Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?
August 21, 2023
Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.
Via
InvestorPlace
US Stocks Mostly Higher; Nasdaq Jumps 100 Points
August 21, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via
Benzinga
Timber Pharmaceuticals to be Acquired by LEO Pharma
August 21, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 18, 2023
Via
Benzinga
Timber Pharmaceuticals Discloses Communication From NYSE American
July 03, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
June 20, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 06, 2023
Via
Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
June 06, 2023
Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.
Via
Benzinga
Dow Drops Over 100 Points; Crude Oil Rises
June 05, 2023
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 05, 2023
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
Nasdaq Rises 70 Points; ISM Services PMI Drops In May
June 05, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,...
Via
Benzinga
Timber Pharmaceuticals’ (NYSE American: TMBR) Phase 3 ASCEND Study for TMB-001: A Leap Forward in Congenital Ichthyosis Treatment
June 05, 2023
Significant Progress in Timber Pharmaceuticals' Phase 3 ASCEND Study Timber Pharmaceuticals (NYSE American: TMBR), a clinical-stage biopharmaceutical company specializing in
Via
Spotlight Growth
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Why Are Timber Pharmaceuticals Shares Trading Higher Today
June 05, 2023
The FDA has granted dermal carcinogenicity (CARC) waiver for Timber Pharmaceuticals Inc's (NYSE: TMBR) TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system.
Via
Benzinga
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
June 05, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
May 15, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.